Biostate AI launches K-Dense Beta, validated by Harvard, compressing research cycles from years to days with industry-leading accuracy.
Read MoreHarvard Medical School
Vyome Therapeutics Completes Merger with ReShape Lifesciences; Nasdaq Debut Under Ticker HIND
Vyome Therapeutics completes merger with ReShape Lifesciences; to trade on Nasdaq as Vyome Holdings (HIND) from August 15, 2025.
Read More